Clinical Trial Update: Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating inhaled carbon monoxide as a treatment for idiopathic pulmonary fibrosis, with the study completed and results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Inhaled carbon monoxide (carbon monoxide inhalation)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14